Portfolio news 0

Oxford Nanopore Technologies Plc

Oxford Nanopore - Annual results for the year ended 31 December 2024

Mixergy Ltd

Mixergy Secures £12 Million in Funding Led by Barclays

First Light Fusion Ltd

First Light Fusion Announces Strategic Update

Microbiotica Ltd

Microbiotica presented new data on the mechanism of action of MB097, a clinical-stage drug candidate being developed as a co-therapy in combination with KEYTRUDA® (pembrolizumab) in patients with advanced melanoma

Oxford Nanopore Technologies Plc

Oxford Nanopore expands compatibility with 10x Genomics to unlock deeper insights in single-cell transcriptomics

Quantum Dice

Quantum Dice and Thales offer QRNG-backed HSM for real-time security verification and seamless transition to post-quantum security

Hysata

Hysata and ACWA Power sign game-changing deal to unlock green hydrogen in the Kingdom of Saudi Arabia and the Gulf with world-leading high efficiency electrolysers

First Light Fusion Ltd

Mark Thomas appointed CEO of First Light Fusion

Quantum Motion Technologies

Quantum Motion joint funds Prosperity Partnership to address thermal challenges in quantum computing

Oxa

Sunderland’s self-driving bus project announces Oxa as new autonomy provider